Deferoxamine

Deferoxamine

Form: Lyophilized powder for injection

Strength: 500 mg/vial, 2 g/vial

Reference Brands: Desferal

Category: Anemia

Deferoxamine (Desferal®) is a trusted parenteral iron chelator used in the treatment of acute iron poisoning and chronic iron overload due to frequent blood transfusions, especially in thalassemia and sickle cell disease. Available as 500 mg and 2 g lyophilized powder for injection, it is administered via IV, IM, or subcutaneous infusion. Marketed under the brand Desferal in the US and EU, it’s manufactured under GMP-compliant standards for hospital and clinical use. Ideal for global B2B pharmaceutical procurement. Contact us for bulk export, COAs, and regulatory support documents.

Get Enquiry Back to Listing
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.

Related Products

Deferasirox

Strength: 125 mg, 250 mg, 500 mg

Form: Tablets for Oral Suspension

Reference Brands: Exjade, Jadenu (film-coated)

View Details Get Enquiry
Iron(III)-Isomaltoside Injection

Strength: 100mg/ml

Form: Injection

Reference Brands: Monofer,, Diafer, Monoferric

View Details Get Enquiry
Iron Dextran

Strength: 50 mg/mL

Form: injection

Reference Brands: Dexferrum,INFeD

View Details Get Enquiry
Polysaccharide-Iron Complex

Strength: 150 mg

Form: Capsules

Reference Brands: Niferex, Ferrex 150, Ferrousal

View Details Get Enquiry

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.